Comment: Serotonin syndrome associated with combined sertraline-amitriptyline treatment.
Alderman
C P
CP
Lee
P C
PC
D015057:1-Naphthylamine / Q000009:adverse effects / Q000031:analogs & derivatives*; D000328:Adult; D000639:Amitriptyline / Q000009:adverse effects*; D000929:Antidepressive Agents, Tricyclic / Q000009:adverse effects*; D003866:Depressive Disorder / Q000188:drug therapy; D004347:Drug Interactions; D005260:Female; D006801:Humans; D009422:Nervous System Diseases / Q000139:chemically induced* / Q000503:physiopathology; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects*; D020280:Sertraline
D015057:1-Naphthylamine; D000639:Amitriptyline; D000929:Antidepressive Agents, Tricyclic; D017367:Selective Serotonin Reuptake Inhibitors; D020280:Sertraline